1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
PBX3 is a putative biomarker of aggressive prostate cancer
- Contribution to journal › Article
- 2013
-
Mark
Assessment of Fusion Gene Status in Sarcomas Using a Custom Made Fusion Gene Microarray
- Contribution to journal › Article
- 2011
-
Mark
Fusion Gene Microarray Reveals Cancer Type-Specificity Among Fusion Genes
- Contribution to journal › Article